Edinburgh BioQuarter has appointed Hans Möller, the former chief executive of Scandinavia’s largest science park, as its new director.
Hans will take up this new post in October 2017 and joins Edinburgh BioQuarter from the North East Local Enterprise Partnership, in Newcastle, where he has been Innovation Director since March 2015.
Edinburgh BioQuarter brings together - in one place - young, growing, and established life science companies, the prestigious Royal Infirmary of Edinburgh, the world-renowned University of Edinburgh’s medical teaching school and many of its award-winning research institutes.
Formerly the chief executive of Ideon Science Park in Sweden, Hans will lead a team which will generate inward investment and foster a culture of collaboration and innovation across the site.
Hans Möller said: “This is a big challenge but one which I’m really looking forward to taking on. The opportunity to move to Edinburgh and to head up a new team at Edinburgh BioQuarter was a big draw for me.
“I can see lots of opportunities to develop what is already a really attractive proposition and a unique place. When you look at what is already established at the park – the highly-skilled people, the hospital, the world-class research and the life sciences companies then we have great foundations to work from.”
Edinburgh BioQuarter is a public sector partnership between NHS Lothian, Scottish Enterprise, the University of Edinburgh and the City of Edinburgh Council. The site comprises world renowned capabilities in clinical research and development, academia, healthcare and health informatics.
On behalf of the partners, Hugh Edmiston, chair of the Strategy Board for Edinburgh BioQuarter, said: “We are delighted to welcome Hans Möller to the Edinburgh BioQuarter team and we look forward to him starting in post.
“This is a unique collaboration between four public sector partners and having someone of Hans’ experience and expertise in place is a big step forward in realising the huge potential at Edinburgh BioQuarter.
“We are confident that with Hans now on board, we can truly deliver a place which is unique in terms of offering outstanding healthcare, world-class scientific and medical research and life science collaborations – ultimately benefiting patient care and the economy both locally and nationally.”